Simplex Trading’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $481 | Hold |
100
| – | – | ﹤0.01% | 8961 |
|
|
2026
Q1 | $340 | Buy |
+100
| New | +$339 | ﹤0.01% | 8781 |
|
|
2025
Q2 | – | Sell |
-800
| Closed | -$1K | – | 9453 |
|
|
2025
Q1 | $1K | Sell |
800
-700
| -47% | -$1.61K | ﹤0.01% | 8273 |
|
|
2024
Q4 | $3K | Buy |
+1,500
| New | +$3.56K | ﹤0.01% | 7904 |
|
|
2024
Q3 | – | Sell |
-4,100
| Closed | -$10K | – | 9273 |
|
|
2024
Q2 | $10K | Buy |
4,100
+2,700
| +193% | +$6.42K | ﹤0.01% | 7436 |
|
|
2024
Q1 | $4K | Buy |
+1,400
| New | +$3.92K | ﹤0.01% | 8146 |
|
|
2023
Q4 | – | Sell |
-2,800
| Closed | -$7K | – | 9543 |
|
|
2023
Q3 | $7K | Sell |
2,800
-300
| -10% | -$945 | ﹤0.01% | 7443 |
|
|
2023
Q2 | $11K | Sell |
3,100
-2,000
| -39% | -$6.41K | ﹤0.01% | 7330 |
|
|
2023
Q1 | $11K | Sell |
5,100
-2,700
| -35% | -$8.58K | ﹤0.01% | 7471 |
|
|
2022
Q4 | $93K | Buy |
7,800
+3,100
| +66% | +$24.1K | ﹤0.01% | 5174 |
|
|
2022
Q3 | $30K | Buy |
4,700
+4,200
| +840% | +$34K | ﹤0.01% | 7081 |
|
|
2022
Q2 | $2K | Sell |
500
-5,700
| -92% | -$30.5K | ﹤0.01% | 9399 |
|
|
2022
Q1 | $53K | Sell |
6,200
-3,300
| -35% | -$33.8K | ﹤0.01% | 7049 |
|
|
2021
Q4 | $135K | Sell |
9,500
-300
| -3% | -$6.27K | ﹤0.01% | 5769 |
|
|
2021
Q3 | $130K | Hold |
9,800
| – | – | ﹤0.01% | 6246 |
|
|
2021
Q2 | $131K | Buy |
+9,800
| New | +$112K | ﹤0.01% | 6348 |
|
|
2021
Q1 | – | Sell |
-4
| Closed | -$1K | – | 9703 |
|
|
2020
Q4 | $1K | Buy |
+4
| New | +$13 | ﹤0.01% | 8141 |
|
|
2020
Q1 | – | Sell |
-324
| Closed | -$166K | – | 8074 |
|
|
2019
Q4 | $166K | Buy |
324
+307
| +1,806% | +$1.15K | ﹤0.01% | 3956 |
|
|
2019
Q3 | $5K | Buy |
17
+13
| +325% | +$43 | ﹤0.01% | 6624 |
|
|
2019
Q2 | $1K | Buy |
+4
| New | +$14 | ﹤0.01% | 6896 |
|
|
2019
Q1 | – | Sell |
-10
| Closed | -$3K | – | 7653 |
|
|
2018
Q4 | $3K | Hold |
10
| – | – | ﹤0.01% | 6444 |
|
|
2018
Q3 | $4K | Buy |
+10
| New | +$52 | ﹤0.01% | 6855 |
|
|
2016
Q2 | – | Sell |
-9
| Closed | -$1K | – | 6285 |
|
|
2016
Q1 | $1K | Buy |
+9
| New | +$60 | ﹤0.01% | 5193 |
|
|
2015
Q1 | – | Sell |
-2
| Closed | -$1K | – | 5420 |
|
|
2014
Q4 | $1K | Buy |
+2
| New | +$13 | ﹤0.01% | 4213 |
|
Other funds holding ORMP
AF
GIA
M
BCM
BFM
Simplex Trading's ORMP Position: Q2 2026 in Review
Simplex Trading sold out of Oramed Pharmaceuticals (ORMP) in Q2 2026, closing a stake of 374 shares — an estimated $1.49K sold.
Simplex Trading first reported a position in ORMP in Q4 2014 and held it in 21 quarters. The position peaked at $462K in Q4 2022. 84 funds tracked by Wall St. Rank hold ORMP as of Q2 2026.
- Simplex Trading reported no remaining Oramed Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Simplex Trading sold 374 Oramed Pharmaceuticals shares in Q2 2026, an estimated $1.49K.
- Simplex Trading first reported a position in Oramed Pharmaceuticals in Q4 2014 and held it in 21 quarters.
- Simplex Trading's Oramed Pharmaceuticals position peaked at $462K in Q4 2022.
- 84 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.